Evidence map›Paper›PMID 40123555›Full record

Observational studyJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2025

Oral appliance therapy is highly efficacious at reducing sleep apnea-specific hypoxic burden, a metric predictive of cardiovascular morbidity and mortality.

Erin V Mosca, Joshua Grosse, John E Remmers

3 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03011762 nacompletednot on this map

Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favorable Candidates for Oral Appliance Therapy

TypeinterventionalSponsorZephyr Sleep TechnologiesRan2012 to 2016Enrolled202ConditionsSleep Apnea, ObstructiveArmsComputer controlled mandibular positioner
NCT03217383 nacompletednot on this map

Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy

TypeinterventionalSponsorZephyr Sleep TechnologiesRan2017 to 2019Enrolled75ConditionsSleep Apnea, Sleep Apnea, Obstructive, Sleep Disordered BreathingArmsMATRx plus
NCT03812692 completednot on this map

Validation of a Simplified MATRx Plus Theragnostic Sleep Study

TypeobservationalSponsorZephyr Sleep TechnologiesRan2019 to 2021Enrolled59ConditionsObstructive Sleep ApneaArmsMATRx plus
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Increasing reports and shifting categorical trends in adverse events for oral appliances.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  2. Article
  3. Article
  4. Mandibular advancement devices in severe obstructive sleep apnea: a second-line option that deserves greater recognition.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erin V MoscaProSomnus Sleep Technologies, Pleasanton, California.
Joshua GrosseProSomnus Sleep Technologies, Pleasanton, California.
John E RemmersProSomnus Sleep Technologies, Pleasanton, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesA surrogate metric of obstructive sleep apnea (OSA), sleep apnea-specific hypoxic burden (SASHB), predicts adverse health outcomes associated with the disease and may be useful in assessing therapeutic success. The purpose of this study was to compare outcomes of mandibular protruding oral appliance therapy using apnea-hypopnea index and SASHB in a population with a spectrum of OSA severity.

methodsIndividuals with mild, moderate, or severe OSA (n = 152) were treated with mandibular protruding oral appliance therapy in a prospective observational study. Two-night home sleep apnea tests were used to determine baseline and outcome values of apnea-hypopnea index and SASHB.

resultsMean baseline SASHB differed by OSA severity strata, with 0%, 19%, and 94% percent of study participants with mild, moderate, and severe OSA, respectively, having values greater than 60%min/h. At outcome, these values were reduced to 0%, 0%, and 15%, respectively. For the entire population, therapeutic efficacy was 78% using apnea-hypopnea index < 10 events/h as a response criterion and 95% using SASHB < 60%min/h as the criterion.

conclusionsUsing a risk-predictive outcome surrogate to assess the efficacy of oral appliance therapy yields a substantially higher estimate of therapeutic efficacy of oral appliance therapy, particularly in patients with severe OSA. CLINICAL

trial registrationRegistry: ClinicalTrials.gov; Name: Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favorable Candidates for Oral Appliance Therapy; URL: https://clinicaltrials.gov/study/NCT03011762; Identifier: NCT03011762; Registry: ClinicalTrials.gov; Name: Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy; URL: https://clinicaltrials.gov/study/NCT03217383; Identifier: NCT03217383; Registry: ClinicalTrials.gov; Name: Validation of a Simplified MATRx Plus; URL: https://clinicaltrials.gov/study/NCT03812692; Identifier: NCT03812692. CITATION: Mosca EV, Grosse J, Remmers JE. Oral appliance therapy is highly efficacious at reducing sleep apnea-specific hypoxic burden, a metric predictive of cardiovascular morbidity and mortality.

Indexed as

Cardiovascular DiseasesHypoxiaMandibular AdvancementSleep Apnea, ObstructiveAdultFemaleHumansMaleMiddle AgedPolysomnographyProspective StudiesSeverity of Illness IndexTreatment Outcomemandibular advancement devicemedical deviceobstructive sleep apneaoral appliance therapysleep apnea-specific hypoxic burdentreatment outcomes

Identifiers

PMID40123555
PMCPMC12225267

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.